Jonathan Couchman is 10% Owner at ENZON PHARMACEUTICALS, INC. (ENZN). They have made 6 open-market trades across 1 company since 2018, most recently 2025-08-20.
CIK 0001265094
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $781K since 2018, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ENZN | SELL | 2020-08-24 | 2020-08-26 | $0.18 | $14K | N/A | N/A | N/A |
| ENZN | BUY | 2019-02-11 | 2019-02-14 | $0.25 | $8K | N/A | N/A | N/A |
| ENZN | BUY | 2018-12-21 | 2019-01-09 | $0.27 | $84K | N/A | N/A | N/A |
| ENZN | BUY | 2018-12-20 | 2019-01-09 | $0.24 | $51K | N/A | N/A | N/A |
| ENZN | BUY | 2018-08-15 | 2019-01-09 | $0.25 | $379K | N/A | N/A | N/A |
| ENZN | BUY | 2018-04-13 | 2019-01-09 | $0.26 | $259K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.